FFP
AVNS

FourThought Financial Partners’s Avanos Medical AVNS Stock Holding History

FourThought Financial Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,965
Closed -$161K – 518
2025
Q3 		$161K Buy
+13,965
New +$164K 0.01% 492

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FourThought Financial Partners's AVNS Position: Q4 2025 in Review

FourThought Financial Partners sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 13,965 shares — an estimated $161K sold.

FourThought Financial Partners first reported a position in AVNS in Q3 2025 and held it in 1 quarter. The position peaked at $161K in Q3 2025. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

  • FourThought Financial Partners reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
  • FourThought Financial Partners sold 13,965 Avanos Medical shares in Q4 2025, an estimated $161K.
  • FourThought Financial Partners first reported a position in Avanos Medical in Q3 2025 and held it in 1 quarter.
  • FourThought Financial Partners's Avanos Medical position peaked at $161K in Q3 2025.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on FourThought Financial Partners's 13F filing for Q4 2025, filed 6 Feb 2026.